» Articles » PMID: 21036854

Evaluation of Three Commercially Available Japanese Encephalitis Virus IgM Enzyme-linked Immunosorbent Assays

Overview
Specialty Tropical Medicine
Date 2010 Nov 2
PMID 21036854
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

We evaluated performance of three commercial Japanese encephalitis virus (JEV) IgM antibody capture enzyme-linked immunosorbent assay (MAC ELISA) kits with a panel of serological specimens collected during a surveillance project of acute encephalitis syndrome in India and acute meningitis and encephalitis syndrome in Bangladesh. The serum and cerebral spinal fluid specimens had been referred to the Centers for Disease Control and Prevention (CDC) for confirmatory testing. The CDC results and specimen classifications were considered the reference standard. All three commercial kits had high specificity (95-99.5%), but low sensitivities, ranging from 17-57%, with both serum and cerebrospinal fluid samples. Specific factors contributing to low sensitivity compared with the CDC ELISA could not be determined through further analysis of the limits and dilution end points of IgM detection.

Citing Articles

Harnessing the Power of AI to Improve Detection, Monitoring, and Public Health Interventions for Japanese Encephalitis.

Xiao J, Kendal E, Kwa F Biomedicines. 2025; 13(1).

PMID: 39857626 PMC: 11763293. DOI: 10.3390/biomedicines13010042.


Central nervous system infection in a pediatric population in West Java.

Alisjahbana D, Nurmawati S, Milanti M, Djauhari H, Ledermann J, Antonjaya U PLoS Negl Trop Dis. 2023; 17(11):e0011769.

PMID: 38011279 PMC: 10703213. DOI: 10.1371/journal.pntd.0011769.


Deep Proteomics Network and Machine Learning Analysis of Human Cerebrospinal Fluid in Japanese Encephalitis Virus Infection.

Bharucha T, Gangadharan B, Kumar A, Myall A, Ayhan N, Pastorino B J Proteome Res. 2023; 22(6):1614-1629.

PMID: 37219084 PMC: 10246887. DOI: 10.1021/acs.jproteome.2c00563.


Effectiveness of introduction of JEV vaccination into routine immunization program in a tribal district of Odisha.

Kshatri J, Pattnaik M, Badaik G, Choudhary H, Mansingh A, Pati S J Family Med Prim Care. 2022; 11(5):1798-1803.

PMID: 35800514 PMC: 9254861. DOI: 10.4103/jfmpc.jfmpc_1335_21.


Immunoglobulin M seroneutralization for improved confirmation of Japanese encephalitis virus infection in a flavivirus-endemic area.

Bharucha T, Ayhan N, Pastorino B, Rattanavong S, Vongsouvath M, Mayxay M Trans R Soc Trop Med Hyg. 2022; 116(11):1032-1042.

PMID: 35593182 PMC: 9623734. DOI: 10.1093/trstmh/trac036.


References
1.
Burke D, Nisalak A, Ussery M . Antibody capture immunoassay detection of japanese encephalitis virus immunoglobulin m and g antibodies in cerebrospinal fluid. J Clin Microbiol. 1982; 16(6):1034-42. PMC: 272535. DOI: 10.1128/jcm.16.6.1034-1042.1982. View

2.
Ravi V, Desai A, Balaji M, Apte M, Lakshman L, Subbakrishna D . Development and evaluation of a rapid IgM capture ELISA (JEV-Chex) for the diagnosis of Japanese encephalitis. J Clin Virol. 2006; 35(4):429-34. DOI: 10.1016/j.jcv.2005.11.004. View

3.
Roehrig J, Johnson A, HUNT A, Bolin R, Chu M . Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation. Virology. 1990; 177(2):668-75. DOI: 10.1016/0042-6822(90)90532-v. View

4.
Roehrig J, MATHEWS J, TRENT D . Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies. Virology. 1983; 128(1):118-26. DOI: 10.1016/0042-6822(83)90323-9. View

5.
Burke D, Nisalak A, Ussery M, Laorakpongse T, Chantavibul S . Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. J Infect Dis. 1985; 151(6):1093-9. DOI: 10.1093/infdis/151.6.1093. View